Get started
Author

Roger Gaertner

Observed name: Gaertner, Roger
Observed institution: AbbVie Canada (Canada)
ORCID: 0009-0006-9956-3197
Observed ORCID: 0009-0006-9956-3197
OpenAlex ID: A5114172186
Eight-week glecaprevir/pibrentasvir in Canadian hepatitis C virus-infected, treatment-naïve, compensated cirrhotic people: CREST study
2024 · Brian Conway, Curtis Cooper, et al. · Future Virology · 1
PDF
Real-World Effectiveness of Upadacitinib on Early and Sustained Pain Control in Canadian Patients with Axial Spondyloarthritis: Interim Results from the Upstand Study
2026 · Louis Bessette, Glen TD Thomson, et al. · The Journal of Rheumatology
Persistence and effectiveness of upadacitinib and TNFi for rheumatoid arthritis using pooled data from Canadian and Swiss registries
2026 · Denis Choquette, Axel Finckh, et al. · Rheumatology
Impact of a Simplified Care Model on Direct-acting Antiviral Treatment for Hepatitis C Virus-positive People in Addiction Care: A Retrospective Review of the trueNorth Medical Centres Database
2024 · Chris Cavacuiti, Roger Gaertner, et al. · The Canadian Journal of Addiction
Works count: 5
Citation count: 1
H-index: 1
I10-index:
Year
Topic
Type